These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6207736)

  • 1. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
    Katz MM; Maas JW; Frazer A; Koslow SH; Bowden CL; Berman N; Swann AC; Stokes PE
    Neuropsychopharmacology; 1994 Oct; 11(2):89-100. PubMed ID: 7530963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
    Maas JW; Kocsis JH; Bowden CL; Davis JM; Redmond DE; Hanin I; Robins E
    Psychol Med; 1982 Feb; 12(1):37-43. PubMed ID: 6177015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
    Davis JM; Koslow SH; Gibbons RD; Maas JW; Bowden CL; Casper R; Hanin I; Javaid JI; Chang SS; Stokes PE
    Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine.
    Bowden CL; Koslow S; Maas JW; Davis J; Garver DL; Hanin I
    J Psychiatr Res; 1987; 21(2):111-28. PubMed ID: 3295209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1986 Oct; 43(10):1012-3. PubMed ID: 2428327
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
    Mooney JJ; Schatzberg AF; Cole JO; Samson JA; Waternaux C; Gerson B; Pappalardo KM; Schildkraut JJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):339-43. PubMed ID: 1770151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression.
    Janicak PG; Davis JM; Chan C; Altman E; Hedeker D
    Am J Psychiatry; 1986 Nov; 143(11):1398-402. PubMed ID: 3777227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF GABA in depressed patients and normal controls.
    Roy A; Dejong J; Ferraro T
    Psychol Med; 1991 Aug; 21(3):613-8. PubMed ID: 1719577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE; Katz MM; Maas JW; Swann A; Casper R; Davis JM
    Arch Gen Psychiatry; 1986 Oct; 43(10):938-47. PubMed ID: 2428328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 17. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to correlate urinary MHPG with clinical response to amitriptyline.
    Puzynski S; Rode A; Bidzinski A; Mrozek S; Zaluska M
    Acta Psychiatr Scand; 1984 Feb; 69(2):117-20. PubMed ID: 6702474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.